Figure 1 | Scientific Reports

Figure 1

From: Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh

Figure 1

Flow chart showing the enrollment and follow-up of the participants receiving different COVID-19 vaccines as primary doses. Number of participants with RT-PCR-confirmed SARS-CoV-2 infection or COVID-like symptoms before enrollment and during follow-up visits as well as the number of participants, who lost to follow-up or received the third or booster dose are shown. *Participants with COVID-like symptoms were tested positive for SARS-CoV-2 Nucleocapsid (N)-specific antibodies. COVID-19: Corona virus diseases 2019; SARS-CoV-2: Severe Acute respiratory Coronavirus-2; RT-PCR: Reverse transcription polymerase chain reaction.

Back to article page